TACKLING health inequity by developing medicines for neglected diseases.

BREAKTHROUGH: Moxidectin Approved by FDA

Latest News: MDGH Seeks Clinical Project Manager

Who we are

We are an independent biopharmaceutical company dedicated to the development of affordable medicines and vaccines for the people who need them most.

Medicines Development for Global Health uses all funds in excess of running costs to develop medicines and vaccines that may have limited commercial opportunity, but address important unmet medical needs.

Why We Do What We Do

There are a billion reasons why. Over 1 billion people suffer from neglected diseases worldwide. We’re focusing our collective expertise on eliminating these diseases, one by one.

Our Team

Very few things we do can be as impactful as a medicine to treat or prevent a disease.

Our Pipeline

Site by